Press Releases - Nykode
Nykode Therapeutics reports Q2 2024 Financial Results. 21/08/2024. Nykode Therapeutics Announces Strategic Repositioning of VB10.16 to Focus on Locally Advanced Cervical Cancer and Recurrent Metastatic Head and Neck Cancer. Load more.
Nykode Therapeutics Announces Updates on its Inverse Vaccine …
OSLO, Norway, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies ...
Home - Nykode
6 days ago · The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.
Nykode Therapeutics Announces Topline Conclusions Affirming …
OSLO, Norway, March 21, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel...
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine …
OSLO, Norway, June 11, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel...
Nykode Therapeutics Announces Updates on its Inverse Vaccine …
Nov 6, 2024 · About Nykode Therapeutics Nykode Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies with a focus on the treatment of cancer and autoimmune diseases. Nykode’s modular vaccine technology specifically targets antigens to antigen presenting cells (APC), employed with ...
Nykode Therapeutics Announces Topline Conclusions Affirming …
Mar 21, 2024 · Nykode Therapeutics ASA. Updated survival data from Phase 2 trial (C-02) in advanced cervical cancer affirm prolonged benefits and indicate a synergistic treatment effect of Nykode’s VB10.16...
Nykode Therapeutics Announces Advances in the Inverse Vaccine …
Mar 19, 2024 · Nykode employs its unique technology platform to pioneer the field of inverse vaccines, with the potential to develop high-precision treatments for autoimmune diseases.
Nykode Therapeutics (Formerly Vaccibody - Business Wire
Nov 23, 2021 · Nykode Therapeutics’ modular vaccine technology specifically targets antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting antigen specific immune...
Nykode Therapeutics Announces Positive Results from the
Sep 27, 2022 · Nykode’s vaccine candidate boosted Spike-specific T cell responses and induced de novo T cell responses to non-Spike antigens found across SARS-CoV-2 variants
- Some results have been removed